CASA Looking For New Executive Director

Jul 09, 2020

The Canadian Agricultural Safety Association (CASA) is looking for a new Executive Director.

Marcel Hacault after serving in the role for the last 16 years has announced his plans to retire.

Hacault has lead CASA since 2004, spearheading the organization's transformation from a safety grant administrator to an organization that leads national efforts to improve agricultural safety across Canada.

Carolyn Van Den Heuvel, Chair of CASA, says Marcel has been a great ambassador for agricultural health and safety.

"Marcel’s leadership has resulted in the establishment of provincial safety groups that directly support farmers. His influence can be seen in initiatives such as the BeGrainSafe program, Back to Ag program, and the Canadian partnership with Progressive Ag Foundation in the delivery of Safety Days.

Hacault says CASA has been a wonderful organization to help lead and grow, adding he's enjoyed the job and the terrific people he's had the chance to work with.

Hacault will remain in his position as Executive Director until March 2021 to help with the transition.

Click here to see more...

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.